Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group
about
Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionImpact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology GroupCancer survival among children of Turkish descent in Germany 1980-2005: a registry-based analysis.Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.Geographic and ethnic differences in childhood leukaemia and lymphoma survival: comparisons of Philippine residents, Asian Americans and Caucasians in the United States.DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group.Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy.High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.Health disparities are important determinants of outcome for children with solid tumor malignancies.In search of targeted therapies for childhood cancer.Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.Disparities in cancer outcomes: lessons learned from children with cancerTreatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in CaliforniaAdvanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology groupOutcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study.Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors.Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study.Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.Improved outcome in pediatric AML due to augmented supportive care.Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.Cultural influences in pediatric cancer from diagnosis to cure/end of life.Complications preceding early deaths in Black and White children with acute myeloid leukemia.Genome-wide association of white blood cell counts in Hispanic/Latino Americans: the Hispanic Community Health Study/Study of Latinos.Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables.Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005.Infection-related mortality in Hispanic and non-Hispanic children with cancer.
P2860
Q24187927-804BA063-B1F8-4C33-8623-5600CD0768C0Q28755379-EED7ADC1-B324-438E-8E19-5D79346B4FCBQ33387989-910762E6-EADA-4F52-8F41-8F32E17746ACQ33960326-DF19B29A-AE20-4024-886D-50A25BE61B6FQ34000307-4686C2DD-0F3B-4019-A568-81FCBE06C419Q34038587-5911C744-BE4F-4CCF-891C-997BC1105AE9Q34043467-0F8A9287-0803-495B-AFA7-ABFC473F6E62Q34080807-D126169D-DA74-48A3-B745-2DFB995676EAQ34662881-AEDA5BBF-2C6E-4E5A-9DB7-85C30395DFD5Q34674124-C8D53ABC-5B86-47B9-B1CA-8FC53CCE52FEQ35112199-13BB39AB-DCDD-403F-88E9-81460C4FB642Q35209900-F89F6877-7433-402D-9255-688A241FDAB9Q35265653-DB624785-E027-4703-BB36-48C3525B08DAQ35530413-EE2A66B4-6610-45E9-A885-24BA8E3A1DF1Q35535515-4591304D-B7C1-4A6C-93CF-F5FACA36EA8EQ35971733-2D74592E-5D5F-45F5-948A-3FC499FD60C7Q35987611-0C03D8E8-BB9A-48DA-BFB4-E9FBA94F58B6Q36015045-69A96A08-02A6-4565-85B5-D2F044D43590Q36058482-658C35CE-771E-4E89-85EB-EBD733B58CF1Q36085238-0B961569-DAF4-4776-A329-E5214763B3D2Q36253767-AF846427-BDC3-48A1-9700-B2C437216063Q36380013-38E6E421-8B66-4181-BAE0-3FC2B397EFBCQ36407162-8808E4CC-C6A0-4192-A989-262751C055E4Q36803785-6B5E0EB7-7FF6-4350-89C1-F0E2AC3F9C7BQ36828419-6E8DED5F-4768-4067-A392-EE9099C3A7EDQ36914531-325D9C60-7B17-4511-A666-B079338B28C1Q37119899-46FEF3F1-B4C0-434A-A6C2-8933A5232081Q37353491-D9AD4E29-DD3D-4294-A0D2-825C03A829ADQ37541489-4F373067-BC4A-4906-A896-05E43C465312Q37934964-848A4FEB-69F3-4B4D-8584-BF5A08547967Q38012400-B02607B6-FE05-474D-9CD2-ED82743FEAF0Q38196743-CC4B449B-BED1-4435-BE82-B6992A629382Q38228294-43D000AC-D686-472C-B255-F807948AD9FDQ38654476-91C39CD9-57A5-40C3-99F5-7CACF9B01004Q38980525-C197D706-6A56-4336-83F3-F5EC9D0F44F4Q39115390-4932B63C-925B-4B2A-90A6-DE77E3B046FEQ39175238-9874DDF4-5DDB-41D2-850D-41C1C76D6138Q39369458-E2690CCF-963A-4880-B1CB-12B8D4362898Q39818023-5DE85BA1-2F76-4936-8CC4-566A318A700AQ40240367-4D4AC8A6-5564-49AC-B15E-3B83D7F96824
P2860
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ethnicity and survival in chil ...... the Children's Oncology Group
@ast
Ethnicity and survival in chil ...... the Children's Oncology Group
@en
type
label
Ethnicity and survival in chil ...... the Children's Oncology Group
@ast
Ethnicity and survival in chil ...... the Children's Oncology Group
@en
prefLabel
Ethnicity and survival in chil ...... the Children's Oncology Group
@ast
Ethnicity and survival in chil ...... the Children's Oncology Group
@en
P2093
P2860
P1433
P1476
Ethnicity and survival in chil ...... the Children's Oncology Group
@en
P2093
Beverly J Lange
Children's Oncology Group
Franklin O Smith
John Perentesis
Julie A Ross
Richard Aplenc
Robert B Gerbing
Soheil Meshinchi
Stella M Davies
Todd A Alonzo
P2860
P356
10.1182/BLOOD-2005-10-4004
P407
P577
2006-03-14T00:00:00Z